2019
DOI: 10.1080/09273948.2018.1560477
|View full text |Cite
|
Sign up to set email alerts
|

Decreased Expression of TGR5 in Vogt-Koyanagi-Harada (VKH) Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(10 citation statements)
references
References 36 publications
2
8
0
Order By: Relevance
“…To verify whether our findings in animals can be extrapolated to humans, we selected two types of clinical uveitis, namely VKH disease and BD, representing an autoimmune disease and an autoinflammatory disease, respectively. In line with our previous study demonstrating decreased TGR5 expression on macrophages in active VKH disease patients (Yang et al, 2020), we herein demonstrated a decreased expression of TGR5 on DCs in both active BD and active VKH disease patients. INT-777 and DCA both inhibited pro-inflammatory cytokine and surface marker expression in Mo-DCs from BD and VKH disease patients in association with a decreased NF-kB activation.…”
Section: Discussionsupporting
confidence: 93%
See 3 more Smart Citations
“…To verify whether our findings in animals can be extrapolated to humans, we selected two types of clinical uveitis, namely VKH disease and BD, representing an autoimmune disease and an autoinflammatory disease, respectively. In line with our previous study demonstrating decreased TGR5 expression on macrophages in active VKH disease patients (Yang et al, 2020), we herein demonstrated a decreased expression of TGR5 on DCs in both active BD and active VKH disease patients. INT-777 and DCA both inhibited pro-inflammatory cytokine and surface marker expression in Mo-DCs from BD and VKH disease patients in association with a decreased NF-kB activation.…”
Section: Discussionsupporting
confidence: 93%
“…Gut microbiota and their metabolites have been implicated as potential modulators of the immune response in inflammatory and autoimmune diseases, including autoimmune uveitis (Huang et al, 2018a;Kalyana Chakravarthy et al, 2018;Maukonen et al, 2015;Nakamura et al, 2016;Stoll et al, 2014;Tremlett et al, 2016;Ye et al, 2018Ye et al, , 2020. Our current study revealed a decreased level of Ruminococcaceae and Lachnospiraceae in EAU mouse feces, the two of which have been previously identified to be decreased in various autoimmune diseases such as inflammatory bowel disease (Maukonen et al, 2015), pediatric multiple sclerosis (Tremlett et al, 2016), inflammatory uveitis (Kalyana Chakravarthy et al, 2018), enthesitis-related arthritis (Stoll et al, 2014), and type 1 diabetes (Candon et al, 2015).…”
Section: Discussionsupporting
confidence: 59%
See 2 more Smart Citations
“…TGR5 is expressed in macrophages and TGR5 agonist attenuates inflammation factor release in atherosclerosis 16 , experimental autoimmune encephalomyelitis 17 and inflammatory bowel diseases 18 , 19 . Besides, TGR5 activation in macrophages co-cultured with CD4 + T cells inhibited Th1 and Th17 polarization in Vogt-Koyanagi-Harada disease 20 . All these indicated that TGR5 in macrophage plays a role in regulating inflammatory response.…”
Section: Introductionmentioning
confidence: 94%